# Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery

> **NCT00491049** · PHASE4 · COMPLETED · sponsor: **Ludwig-Maximilians - University of Munich** · enrollment: 140 (actual)

## Conditions studied

- Conjunctival Bacterial Flora

## Interventions

- **DRUG:** 0.5% levofloxacin eye drops

## Key facts

- **NCT ID:** NCT00491049
- **Lead sponsor:** Ludwig-Maximilians - University of Munich
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2007-06-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491049, "Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00491049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*